Envoy Medical Inc (COCH)

$2.28

-0.11

(-4.6%)

Market is closed - opens 7 PM, 16 Jul 2024

Performance

  • $2.28
    $2.38
    $2.28
    downward going graph

    0.0%

    Downside

    Day's Volatility :4.08%

    Upside

    4.08%

    downward going graph
  • $0.75
    $11.72
    $2.28
    downward going graph

    67.22%

    Downside

    52 Weeks Volatility :93.62%

    Upside

    80.55%

    downward going graph

Returns

PeriodEnvoy Medical Inc
3 Months
-61.68%
6 Months
49.21%
1 Year
-78.18%
3 Years
-76.35%

Highlights

Market Capitalization
26.4M
Book Value
$0.25
Earnings Per Share (EPS)
-1.97
Wall Street Target Price
4.0
Profit Margin
0.0%
Operating Margin TTM
-4231.25%
Return On Assets TTM
0.0%
Return On Equity TTM
0.0%
Revenue TTM
241.0K
Revenue Per Share TTM
0.0
Quarterly Revenue Growth YOY
40.400000000000006%
Gross Profit TTM
-720.0K
EBITDA
-14.4M
Diluted Eps TTM
-1.97
Quarterly Earnings Growth YOY
0.0
EPS Estimate Current Year
-1.66
EPS Estimate Next Year
-0.78
EPS Estimate Current Quarter
0.0
EPS Estimate Next Quarter
0.0

Analyst Recommendation

Buy
    88%Buy
    11%Hold
    0
    0%Sell
Based on 9 Wall street analysts offering stock ratings for Envoy Medical Inc(by analysts ranked 0 to 5 stars)
Based on 9 analyst
  • Current
  • 1M Ago
  • 3M Ago
Buy
8
8
8
Hold
1
1
1
Sell
00
00
00

Analyst Forecast

What analysts predicted

Upside of 75.44%

Current $2.28
Target $4.00

Company Financials

FY21Y/Y Change
Revenue
310.0K
-
Net Income
-8.7M
↑ 1237417.83%
Net Profit Margin
-2.8K%
-
FY22Y/Y Change
Revenue
237.0K
↓ 23.55%
Net Income
-15.9M
↑ 83.55%
Net Profit Margin
-6.7K%
↓ 3920.18%
FY23Y/Y Change
Revenue
316.0K
↑ 33.33%
Net Income
-29.9M
↑ 87.83%
Net Profit Margin
-9.5K%
↓ 2745.99%
Q4 FY22Q/Q Change
Revenue
20.0K
↓ 64.91%
Net Income
-11.5M
↑ 757.13%
Net Profit Margin
-57.4K%
↓ 55035.88%
Q1 FY23Q/Q Change
Revenue
78.0K
↑ 290.0%
Net Income
717.7K
↓ 106.25%
Net Profit Margin
920.13%
↑ 58305.13%
Q2 FY23Q/Q Change
Revenue
63.0K
↓ 19.23%
Net Income
-13.2M
↓ 1945.62%
Net Profit Margin
-21.0K%
↓ 21945.53%
Q3 FY23Q/Q Change
Revenue
80.0K
↑ 26.98%
Net Income
1.6M
↓ 111.8%
Net Profit Margin
2.0K%
↑ 22979.15%
Q4 FY23Q/Q Change
Revenue
95.0K
↑ 18.75%
Net Income
-4.9M
↓ 412.28%
Net Profit Margin
-5.1K%
↓ 7091.64%
Q1 FY24Q/Q Change
Revenue
59.0K
↓ 37.89%
Net Income
-6.3M
↑ 28.46%
Net Profit Margin
-10.6K%
↓ 5489.23%
FY20Y/Y Change
Total Assets
120.0K
-
Total Liabilities
95.7K
-
FY21Y/Y Change
Total Assets
2.6M
↑ 2086.81%
Total Liabilities
47.6M
↑ 49625.69%
FY22Y/Y Change
Total Assets
2.6M
↓ 2.59%
Total Liabilities
58.7M
↑ 23.41%
FY23Y/Y Change
Total Assets
7.6M
↑ 198.9%
Total Liabilities
9.4M
↓ 83.99%
Q4 FY22Q/Q Change
Total Assets
2.6M
↓ 99.4%
Total Liabilities
58.7M
↑ 221.2%
Q1 FY23Q/Q Change
Total Assets
45.9M
↑ 1696.61%
Total Liabilities
21.0M
↓ 64.28%
Q2 FY23Q/Q Change
Total Assets
2.6M
↓ 94.35%
Total Liabilities
82.3M
↑ 292.18%
Q3 FY23Q/Q Change
Total Assets
23.6M
↑ 810.18%
Total Liabilities
17.3M
↓ 78.92%
Q4 FY23Q/Q Change
Total Assets
7.6M
↓ 67.63%
Total Liabilities
9.4M
↓ 45.78%
Q1 FY24Q/Q Change
Total Assets
8.5M
↑ 10.99%
Total Liabilities
15.9M
↑ 69.04%
FY21Y/Y Change
Operating Cash Flow
-6.9M
-
Investing Cash Flow
-125.0K
-
Financing Cash Flow
8.1M
-
FY22Y/Y Change
Operating Cash Flow
-8.8M
↑ 26.95%
Investing Cash Flow
-218.0K
↑ 74.4%
Financing Cash Flow
8.1M
↑ 0.42%
Q1 FY23Q/Q Change
Operating Cash Flow
-2.2M
↓ 8.38%
Investing Cash Flow
-59.0K
-
Financing Cash Flow
4.0M
↑ 100.0%
Q2 FY23Q/Q Change
Operating Cash Flow
-678.9K
↓ 68.85%
Investing Cash Flow
-11.0K
↓ 81.36%
Financing Cash Flow
3.0M
↓ 25.0%

Technicals Summary

Sell

Neutral

Buy

Envoy Medical Inc is currently not in a favorable trading position ( SELL ) according to technical analysis indicators.

Peers

Company Name1 Month6 Month1 Year3 Years5 Years
Envoy Medical Inc
Envoy Medical Inc
-7.32%
49.21%
-78.18%
-76.35%
-76.3%
Stryker Corporation
Stryker Corporation
-4.68%
4.54%
10.03%
27.55%
59.96%
Boston Scientific Corp.
Boston Scientific Corp.
2.4%
29.49%
48.3%
85.32%
86.38%
Edwards Lifesciences Corp.
Edwards Lifesciences Corp.
3.03%
20.96%
-3.4%
-16.29%
43.18%
Abbott Laboratories
Abbott Laboratories
-0.47%
-9.49%
-3.78%
-12.38%
23.81%
Medtronic Plc
Medtronic Plc
-3.59%
-10.93%
-11.11%
-38.73%
-22.82%
Company NameP/E RatioP/B RatioPEG RatioEPSROEROADiv YieldBVPS
Envoy Medical Inc
Envoy Medical Inc
NA
NA
NA
-1.66
0.0
0.0
NA
0.25
Stryker Corporation
Stryker Corporation
38.74
38.74
2.92
11.95
0.19
0.07
0.01
50.33
Boston Scientific Corp.
Boston Scientific Corp.
65.29
65.29
1.8
2.33
0.09
0.05
NA
13.56
Edwards Lifesciences Corp.
Edwards Lifesciences Corp.
38.58
38.58
5.19
2.76
0.21
0.12
NA
11.82
Abbott Laboratories
Abbott Laboratories
32.47
32.47
5.99
4.63
0.15
0.06
0.02
22.31
Medtronic Plc
Medtronic Plc
28.24
28.24
1.52
5.2
0.07
0.04
0.04
38.29
Company NameAnalyst ViewMarket Cap5 Years Return %PE RatioProfit Margin
Envoy Medical Inc
Envoy Medical Inc
Buy
$26.4M
-76.3%
NA
0.0%
Stryker Corporation
Stryker Corporation
Buy
$129.3B
59.96%
38.74
16.03%
Boston Scientific Corp.
Boston Scientific Corp.
Buy
$114.2B
86.38%
65.29
12.05%
Edwards Lifesciences Corp.
Edwards Lifesciences Corp.
Buy
$53.9B
43.18%
38.58
23.01%
Abbott Laboratories
Abbott Laboratories
Buy
$181.3B
23.81%
32.47
13.96%
Medtronic Plc
Medtronic Plc
Buy
$100.0B
-22.82%
28.24
11.36%

Company Information

Organization
Envoy Medical Inc
Employees
34
CEO
Mr. Brent T. Lucas Esq.
Industry
Miscellaneous

FAQs